TWO SIGMA INVESTMENTS, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$515,364
-8.9%
32,680
+12.3%
0.00%0.0%
Q2 2023$565,782
-89.3%
29,104
-77.1%
0.00%
-92.9%
Q1 2021$5,310,000
+7.9%
127,206
+20.4%
0.01%0.0%
Q4 2020$4,922,000
+121.6%
105,682
+102.2%
0.01%
+75.0%
Q3 2020$2,221,000
+33.2%
52,273
+50.4%
0.01%0.0%
Q2 2020$1,668,000
-66.0%
34,764
-64.2%
0.01%
-50.0%
Q1 2019$4,900,000
+30.4%
97,049
+4.1%
0.02%
+6.7%
Q4 2018$3,757,000
+3.7%
93,260
+94.7%
0.02%
+36.4%
Q2 2018$3,624,000
+36.6%
47,901
+43.3%
0.01%
+10.0%
Q4 2016$2,653,000
+603.7%
33,437
+259.5%
0.01%
+400.0%
Q1 2016$377,000
-76.7%
9,300
-49.0%
0.00%
-75.0%
Q4 2015$1,616,000
-76.0%
18,224
-79.9%
0.01%
-76.5%
Q3 2015$6,727,000
+96.6%
90,870
+114.7%
0.03%
+112.5%
Q2 2015$3,422,000
+73.8%
42,326
-10.0%
0.02%
+60.0%
Q1 2015$1,969,00047,0050.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders